Metagenomi, Inc. (MGX)
NASDAQ: MGX · Real-Time Price · USD
1.900
-0.040 (-2.06%)
Aug 14, 2025, 1:59 PM - Market open
Metagenomi Market Cap
Metagenomi has a market cap or net worth of $71.31 million as of August 14, 2025. Its market cap has decreased by -56.04% in one year.
Market Cap
71.31M
Enterprise Value
-90.74M
1-Year Change
-56.04%
Ranking
Category
Stock Price
$1.90
Market Cap Chart
Since the IPO on February 9, 2024, Metagenomi's market cap has decreased from $562.92M to $71.31M, a decrease of -87.33%. That is a compound annual growth rate of -74.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2025 | 72.81M | -46.10% |
| Dec 31, 2024 | 135.10M | -76.00% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 600.62B |
| Johnson & Johnson | 419.53B |
| AbbVie | 359.55B |
| UnitedHealth Group | 245.40B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 224.99B |